Glenmark Pharmaceuticals

quarterly
yearly
ParticularsMar '25Jun '25Sep '25Dec '25Mar '26
Revenue3,2683,2916,2483,9453,960
Expenses2,8872,8723,8953,2273,199
EBITDA572.72606.972,560914.22951.68
Operating Profit74.68153.811,034575.43430.37
Profit Before Tax7.9795.58967.40534.00387.77
Net Profit4.3846.97610.43403.23301.32
Financial Ratios
Operating Profit Margin6.21%9.27%19.57%18.77%15.38%
Net Profit Margin11.50%8.52%25.57%13.89%14.96%
Earning Per Share (Diluted)0.161.6621.6214.2810.68
Dividends Per Share0.000.000.000.000.00